Slide 1: Faster, more accurate gold analysis
Faster, more accurate gold analysis 1H FY26 Financial Results 18 February 2026 Dirk Treasure, Managing Director and CEO Brett Coventry, CFO
Slide 2: Important notice
Important notice The material in this presentation has been prepared by Chrysos Corporation Limited (ASX: C79) (“Chrysos” or the “Group") and is general background information about Chrysos’ current activities as at the date of this presentation. The information is given in summary form and does not
Slide 3: The Chrysos investment proposition
The Chrysos investment proposition PhotonAssayTM is the mining industry’s most innovative assaying solution Delivering faster, safer, more accurate and environmentally-friendly gold analysis Non-discretionary spend Competitive fee-per-sample model for miners Long-term contracts Strong patent protect
Slide 4: Financial and operating highlights
Financial and operating highlights 1H FY26 Revenue & EBITDA growth demonstrates Chrysos’ operating efficiencies $43.3m $14.3m Total Revenue EBITDA • +49% growth YoY (1H FY25 $29.1m) • +152% growth on 1H FY25 ($5.7m) • MMAP Revenue of $31.5m, AAC Revenue of $11.7m • Economies of scale and increased u
Slide 5: PhotonAssay sample volumes
PhotonAssay sample volumes Continued conversion to PhotonAssay and industry activity driving samples PhotonAssayTM Samples Analysed Quarterly Activity Commentary ■ Sustained PhotonAssayTM demand with volumes approaching 1,000,000 samples per month ■ Increased monthly throughput with consistent growt
Slide 6: Executing on our global PhotonAssay roll out
Executing on our global PhotonAssayTM roll out Strengthening relationships with key miners and laboratories 1H FY26 Activity 43 Units Deployed1 ▪ Four units deployed and one unit at end of lease in 1H FY26, bringing total deployed units to 43: ▪ SGS, Perth, deployed our first “XN” generation unit ▪
Slide 7: Targeted sales strategy
Targeted sales strategy Increasing utilisation supports sustained gross profit per unit Two-pronged sales approach Quarterly PhotonAssayTM samples analysed 3,000,000 2,500,000 Hub & Spoke Deployment Strategy Minesite Deployment Strategy 2,000,000 1,500,000 Laboratory partnerships support Direct to M
Slide 8: Growing PhotonAssay technology adoption
Growing PhotonAssay technology adoption Expanding market penetration and growing engagement with the world’s leading miners Top 20 gold producing companies by 2024 production Notable adoption milestones and endorsements • November 2025: SGS, Perth, installed Chrysos’ first XN generation unit • Augus
Slide 9: 1H FY26 Financial Summary
1H[Insert] FY26 Financial Summary
Slide 10: Diversifying regional revenues
Diversifying regional revenues Continued adoption of PhotonAssayTM and increased industry activity driving revenue growth Revenue1 by Region 49% 50,000 ■ Revenue1 of $43.3m reflects an increase of 49% YoY, driven by Revenue per Region ('000's AUD) 40,000 adoption of PhotonAssayTM and increased indus
Slide 11: Predictable base revenue with accelerating upside
Predictable base revenue with accelerating upside Utilisation-led AAC revenue now represents 27% of 1H FY26 total revenue MMAP, AAC and Other Revenue $50,000 ■ Minimum Monthly Assay Payments (MMAP) provide predictable and $45,000 +49% 1 $43.3m sustainable minimum revenue underpinning the business $4
Slide 12: Revenue & profitability
Revenue & profitability EBITDA margin growing with scale and utilisation #039;000 1H FY25 1H FY26 % change 1 Total Revenue of $43.3m: Reflecting continued global adoption of Revenue 29,075 43,253 PhotonAssay , strong gold market conditions and materially higher Other income 26 59 utilisation across the
Slide 13: Cash flow summary
Cash flow summary Operating leverage translating to cash generation $000's 1HY FY25 1HY FY26 1 EBITDA Growth and Margin Expansion: EBITDA of $14.4m EBITDA 1 5,687 14,350 reflecting an 152% increase from 1H FY25, with an improved Non-Cash Items 2,400 2,459 EBITDA margin of 33%, up from 20% in 1H FY25
Slide 14: Balance sheet
Balance sheet Strong balance sheet provides a solid platform to sustain growth #039;000 30-Jun-25 31-Dec-25 Assets Cash and cash equivalents 21,520 21,567 Trade and other receivables 2 27,707 31,843 1■ Strong Balance Sheet to Support Growth: Strong balance sheet Other current assets (incl prepayments)
Slide 15: Strengthened funding capacity
Strengthened funding capacity Strategic funding to support growth Increased Funding Position $200m Syndicated Facility1 200 ■ Refinances existing debt and expands capacity for growth 175 150 +105m1 ■ Three-year facility ■ Improved pricing versus existing arrangements $AUD Millions 125 100 75 Growth
Slide 16: Strategy
Strategy [Insert]
Slide 17: The Opportunity
The Opportunity Vision: to become the world’s leading provider of innovative assay services and technologies Total Addressable Market (TAM)1 ▪ Convert gold mining projects in all key mining 700 hubs to PhotonAssayTM 610 Sites 600 ▪ Focus on improved customer outcomes to drive sample volumes 500 ~5%
Slide 18: Chrysos growth strategy
Chrysos growth strategy Disseminated market, now with a presence in every region Percentage of miners within total addressable market 13% 13% ■ Established global footprint for PhotonAssayTM technology supported by major global laboratory partners ■ Bureau Veritas agreement supports Chrysos’ deploym
Slide 19: PhotonAssay beyond gold
PhotonAssayTM beyond gold Unlocking further market opportunities Core market focus Additional revenue streams Near-term R&D Long-term potential Commercially Available • Other base metals Detectable Elements • Rare earths • Energy metals Increased revenue Increased per sample sample volume Detectable
Slide 20: FY26 Guidance
CHRYSOS CORPORATION Assays at the spood o* light CHR COR} FY26 Guidance
Slide 21: FY26 Guidance
FY26 Guidance Strong 1H FY26 financial results and sustained high sample volumes FY26 Guidance1: EBITDA and Total Revenue are both trending towards the upper end of their respective guidance ranges: ■ Total Revenue range of between $80m and $90m ■ EBITDA range of between $20m and $27m 1. Guidance se
Slide 22: In summary
In summary Record sample volumes drive first half revenue and EBITDA growth Financial ■ Achieved robust growth of 49% Revenue1 YoY and 152% EBITDA YoY ■ EBITDA of $14.4m, up 152% on 1H FY25, EBITDA margin of 33%, compared to 20% in 1H FY25 Operational ■ 43 PhotonAssayTM units currently deployed, sup
Slide 23: Thank you
Thank you For more information, please visit chrysoscorp.com or contact us at investors@chrysoscorp.com
Slide 24: Appendix: About Chrysos
Appendix: [Insert] About Chrysos
Slide 25: Our commercialisation journey
Our commercialisation journey The outcome of 20+ years of research and development Newmont MSA To use International Prototype Complete JORC and NI43-101 New Customer PhotonAssayTM deployment continues across its 1st PhotonAssayTM Max unit Companies cite PhotonAssayTM Announcements Established Canadi
Slide 26: PhotonAssay technology
PhotonAssayTM technology Efficient, effective and environmentally-friendly minerals analysis Step 1 Step 2 Step 3 The crushed sample Automated high-energy X-ray Automated reporting (2-3 mm) is loaded into analysis, activates and detects gold atoms jars and scanned into Sample can be retained unit by
Slide 27: PhotonAssay Unit Development
PhotonAssayTM Unit Development The next generations of Chrysos’ PhotonAssay analysis Development focus: Supply chain Improved Reduced resilience + performance + maintenance PhotonAssayTM- XN: Even greater PhotonAssayTM - XC: The Aussie efficiency contender ■ A new generation of PhotonAssayTM units,
Slide 28: Delivering tangible benefits for miners
Delivering tangible benefits for miners PhotonAssayTM enables timely decision making and additional gold recovery The opportunity… PhotonAssayTM is embedded in the mining value chain PhotonAssayTM Value Add ■ Each year global miners are Exploration Fast turnaround for mine estimated to lose >$2.0 bi
Slide 29: Unit lifecycle & financial profile
Unit lifecycle & financial profile Unit economics are the underlying strength behind Chrysos’ business -18 Months -9 Months 8-12 weeks 5+5+5+5 year lease model 20 Years Long Lead Time • Detector station components Key steps Initial lease, renewal, recontract Refurbishment or re-use Components integr
Slide 30: Experienced leadership team
Experienced leadership team Supported by a well-respected and tenured board Senior leadership team Board of Directors Dirk Treasure Rob Adamson – appointed June 2016 Kerry Gleeson – appointed July 2021 Founding CEO & Managing Director Founder & Non-Executive Chairman Non-Executive Director • Metallu
Slide 31: Revolutionising the global mining industry
Revolutionising the global mining industry Chrysos is a global provider of novel assay services through its proprietary PhotonAssayTM technology Sample Processed (Half Yearly) Disruptive Minerals Analysis Service and Lease Model with Technology Tier 1 Counterparties 18,000 16,000 Cumulative Sample V